4.8 Review

Diet and depression: exploring the biological mechanisms of action

Journal

MOLECULAR PSYCHIATRY
Volume 26, Issue 1, Pages 134-150

Publisher

SPRINGERNATURE
DOI: 10.1038/s41380-020-00925-x

Keywords

-

Funding

  1. Alfred Deakin Postdoctoral Research Fellowship
  2. Multiple Sclerosis Research Australia
  3. Cancer Council Queensland
  4. Bond University - Nutrition Society of Australia
  5. Nutrition Research Australia
  6. Princess Alexandra Research Foundation - Deakin University
  7. Be Fit Foods
  8. Australian Rotary Health
  9. Deakin University Postgraduate Industry Research Scholarship
  10. NHMRC Senior Principal Research Fellowship [1059660, 1156072]
  11. NIH, Cooperative Research Centre, Simons Autism Foundation
  12. Cancer Council of Victoria
  13. Stanley Medical Research Foundation
  14. Medical Benefits Fund
  15. National Health and Medical Research Council, Medical Research Futures Fund, Beyond Blue
  16. A2 milk company, Meat and Livestock Board, Woolworths, Avant
  17. Harry Windsor Foundation
  18. Bioadvantex
  19. Lundbeck Merck
  20. Pfizer
  21. Servier
  22. Australian Research Council, National Health and Medical Research Council
  23. ChemGenex Pharmaceuticals
  24. Johnson & Johnson - Wellcome Trust strategy award
  25. Alzheimer's Disease (NIMA) Consortium [104025]
  26. GlaxoSmithKline
  27. Pfizer - UK Medical Research Council [MR/L014815/1, MR/J002739/1, MR/N029488/1]
  28. European Commission [SC1-BHC-01-2019]
  29. National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London [2017-2025]
  30. Irish Research Council postdoctoral fellowship
  31. Science Foundation Ireland [SFI/12/RC/2273-P2, 15/JPHDHL/3270]
  32. Joint Programming Initiative HEALTHMARK: Metabolic HEALTH through nutrition,microbiota [16/ERAHDHL/3362]
  33. Swiss National Foundation Sinergia
  34. Irish Research Council
  35. European Union
  36. Irish Research Council Postgraduate Scholarship [GOIPG/2019/3198, GOIPG/2018/2560]
  37. Health Research Board (HRB) [ILP-POR-2017-013]
  38. Saks Kavanaugh Foundation
  39. Mead Johnson
  40. 4D Pharma
  41. Nutricia
  42. Alkermes
  43. Nestle
  44. Roche
  45. Ordesa and Neuraxpharm - Science Foundation Ireland (SFI) [12/RC/2273-P2]
  46. Irish Health Research Board (HRB) [ILP-POR-2017-013]
  47. University of Manchester Presidential Fellowship [P123958]
  48. UK Research and Innovation Future Leaders Fellowship [MR/T021780/1]
  49. NICM-Blackmores Institute Fellowship - Australian Research Council [DP190103081]
  50. National Health and Medical Research Council [APP114333, APP1079102]
  51. Waterloo Foundation
  52. Trajan Scientific and Medical [MOST 106-2314-B-039-027-MY3, 108-2320-B-039-048, 108-2813-C-039-133-B, 108-2314-B-039-016]
  53. Ministry of Science and Technology, Taiwan [NHRI-EX108-10528NI]
  54. National Health Research Institutes, Taiwan [MYRG2018-00242-ICMS]
  55. University of Macau, China [CMRC-CMA-3]
  56. Higher Education Sprout Project by the Ministry of Education (MOE), Taiwan [CMU108-SR-106]
  57. China Medical University, Taichung, Taiwan [CRS-108-048, DMR-108-216, DMR-109-102]
  58. China Medical University Hospital, Taichung, Taiwan
  59. Astra Zeneca
  60. Lundbeck
  61. Eli Lilly
  62. Merck
  63. Otsuka
  64. Excelsior Biopharma
  65. Massachusetts General Hospital Psychiatry Academy
  66. PeerPoint Medical Education Institute, LLC
  67. MGH Clinical Trials Network and Institute (CTNI)
  68. NIMH - NINDS of National Institute of Health
  69. National Sciences and Engineering Research Council of Canada (NSERC)
  70. Ontario Brain Institute
  71. Ontario Government
  72. Fonds Baillet Latour (Grant for Medical Research)
  73. Fonds de la Recherche Scientifique (FNRS) [FRFS-WELBIO: WELBIO-CR-2019C-02R]
  74. ERC Starting Grant [336452-ENIGMO]
  75. Medical Research Council UK [MR/N030087/1, MR/S00484X/1]
  76. Network of Centres of Excellence in Neurodegeneration (COEN)
  77. CD investments VSL pharmaceuticals - Alfred Deakin Postdoctoral Research Fellowship
  78. Centre of Excellence for Neurodegenerative disorders
  79. Future Leader Fellowship [101160]
  80. Heart Foundation Australia and Wilson Foundation
  81. National Health & Medical Research Council
  82. Australian Research Council
  83. Meat and Livestock Australia
  84. Brain and Behaviour Research Institute
  85. National Health and Medical Research Council (NHMRC)
  86. Ian Potter Foundation
  87. Woolworths Limited
  88. Pharmavite
  89. MRC [MR/N029488/1, G108/603] Funding Source: UKRI
  90. Health Research Board (HRB) [ILP-POR-2017-013] Funding Source: Health Research Board (HRB)

Ask authors/readers for more resources

Nutritional psychiatry research suggests that healthy dietary patterns may play a role in depression onset and symptom management. The mechanisms of action are complex, multifaceted, and interact with each other, not restricted to any single biological pathway.
The field of nutritional psychiatry has generated observational and efficacy data supporting a role for healthy dietary patterns in depression onset and symptom management. To guide future clinical trials and targeted dietary therapies, this review provides an overview of what is currently known regarding underlying mechanisms of action by which diet may influence mental and brain health. The mechanisms of action associating diet with health outcomes are complex, multifaceted, interacting, and not restricted to any one biological pathway. Numerous pathways were identified through which diet could plausibly affect mental health. These include modulation of pathways involved in inflammation, oxidative stress, epigenetics, mitochondrial dysfunction, the gut microbiota, tryptophan-kynurenine metabolism, the HPA axis, neurogenesis and BDNF, epigenetics, and obesity. However, the nascent nature of the nutritional psychiatry field to date means that the existing literature identified in this review is largely comprised of preclinical animal studies. To fully identify and elucidate complex mechanisms of action, intervention studies that assess markers related to these pathways within clinically diagnosed human populations are needed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available